BNTX
BioNTech SE
Set alert
88.17 USD -0.96 -1.08%
87.47 Day range 90.32
83.89 52-week range 119.34
- YTD
- -7.38%
- 1 year
- -15.76%
- Open
- 89.22
- Prev close
- 89.13
- Mkt cap
- 22.15B
- Vol
- 631.91K
- Avg vol
- 1.26M
- EPS
- -7.83
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 87.47
- High
- 90.32
- Forward P/E
- -16.31
- Beta
- 1.25
- Short ratio
- 2.35
- Inst. own
- 19.75%
- Dividend
- 0.00
- Ex-div date
- Jun 1, 2022
- Earnings
- Nov 3, 2026
- 50-d avg
- 97.70
- 200-d avg
- 97.20
- 1y target
- 116.66
Discussion (397)
Sign in to join the discussion
Curing cancer is hard people, give the company a break. They will eventually get there and make us millions
This company can’t do anything right with all this cash
70% ORR and safety profile are both extraordinary
Buying to dip
Results were widely expected
What are all these anti mRNA and anti Pharma morons in the comments - hava a life instead of spamming
Will see down grade to $30
If Japan can do it, China is a super copycat country. China will make mRNA vaccine, too.
Japan made mRNA covid vaccine? Japan has started given out their vaccine to their people. Don’t Pfizer or Moderna have patents?